A new oligonucleotide array for the detection of multidrug and extensively drug-resistance tuberculosis
Open Access
- 14 March 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 9 (1), 1-11
- https://doi.org/10.1038/s41598-019-39339-3
Abstract
Drug-resistant tuberculosis (TB) is a global crisis and a threat to health security. Since conventional drug susceptibility testing (DST) takes several weeks, we herein described a molecular assay to rapidly identify multidrug-resistant (MDR) and extensively drug-resistant (XDR) and reveal transmission associated-mutations of Mycobacterium tuberculosis complex (MTBC) isolates in 6 to 7 hours. An array was designed with 12 pairs of primers and 60 single nucleotide polymorphisms of 9 genes: rpoB, katG, inhA, ahpC, embB, rpsL, gyrA, rrs and eis. We assessed the performance of the array using 176 clinical MTBC isolates. The results of culture-based DST were used as the gold standard, the GenoType MTBDRplus and MTBDRsl tests were used for parallel comparison, and gene sequencing was performed to resolve the discordance. The sensitivities and specificities of the array are comparable to those of the MTBDRplus test for resistance to isoniazid (INH) (100.0%, 96.7%) and rifampicin (RIF) (99.4%, 96.7%) and of the MTBDRsl test for resistance to fluoroquinolones (FQs) (100%, 100%) and second-line injectable drugs (SLIDs) (98.3%, 100%). The sensitivities of the array for detecting resistance to ethambutol and streptomycin were 79.3% and 64.9%, respectively. The array has potential as a powerful tool for clinical diagnosis and epidemiological investigations.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST104-2325-B-404-001, MOST105-2325-B-404-001, MOST104-2325-B-404-001, MOST104-2325-B-404-001, MOST105-2325-B-404-001)
- Ministry of Health and Welfare, Taiwan
This publication has 54 references indexed in Scilit:
- Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarraysBMC Infectious Diseases, 2013
- Performance Assessment of the DR. TBDR/NTM IVD Kit for Direct Detection of Mycobacterium tuberculosis Isolates, Including Rifampin-Resistant Isolates, and Nontuberculous MycobacteriaJournal of Clinical Microbiology, 2012
- Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence settingBMC Microbiology, 2012
- A Multisite Assessment of the Quantitative Capabilities of the Xpert MTB/RIF AssayAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Mutations in gidB Confer Low-Level Streptomycin Resistance in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2011
- Real‐Time SNP Analysis in Secondary‐Structure‐Folded Nucleic AcidsAngewandte Chemie-International Edition, 2010
- Allelic Exchange and Mutant Selection Demonstrate that Common Clinical embCAB Gene Mutations Only Modestly Increase Resistance to Ethambutol in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2010
- High Level of Cross-Resistance between Kanamycin, Amikacin, and Capreomycin among Mycobacterium tuberculosis Isolates from Georgia and a Close Relation with Mutations in the rrs GeneAntimicrobial Agents and Chemotherapy, 2009
- Performance Assessment of the GenoType MTBDR plus Test and DNA Sequencing in Detection of Multidrug-Resistant Mycobacterium tuberculosisJournal of Clinical Microbiology, 2009
- Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical SpecimensJournal of Clinical Microbiology, 2007